No muscle damage from clofibrate.
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D002087:Butyrates / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood*; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced*
D000924:Anticholesteremic Agents; D002087:Butyrates; D003402:Creatine Kinase